Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.
2.

A Prospective Analysis of Red and Processed Meat Consumption and Risk of Colorectal Cancer in Women.

Mehta SS, Arroyave WD, Lunn RM, Park YM, Boyd WA, Sandler DP.

Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):141-150. doi: 10.1158/1055-9965.EPI-19-0459. Epub 2019 Oct 1.

PMID:
31575555
3.

The IARC Monographs: Updated Procedures for Modern and Transparent Evidence Synthesis in Cancer Hazard Identification.

Samet JM, Chiu WA, Cogliano V, Jinot J, Kriebel D, Lunn RM, Beland FA, Bero L, Browne P, Fritschi L, Kanno J, Lachenmeier DW, Lan Q, Lasfargues G, Le Curieux F, Peters S, Shubat P, Sone H, White MC, Williamson J, Yakubovskaya M, Siemiatycki J, White PA, Guyton KZ, Schubauer-Berigan MK, Hall AL, Grosse Y, Bouvard V, Benbrahim-Tallaa L, El Ghissassi F, Lauby-Secretan B, Armstrong B, Saracci R, Zavadil J, Straif K, Wild CP.

J Natl Cancer Inst. 2020 Jan 1;112(1):30-37. doi: 10.1093/jnci/djz169.

4.

Welding fumes and lung cancer: a meta-analysis of case-control and cohort studies.

Honaryar MK, Lunn RM, Luce D, Ahrens W, 't Mannetje A, Hansen J, Bouaoun L, Loomis D, Byrnes G, Vilahur N, Stayner L, Guha N.

Occup Environ Med. 2019 Jun;76(6):422-431. doi: 10.1136/oemed-2018-105447. Epub 2019 Apr 4.

PMID:
30948521
5.

Software Tools to Facilitate Systematic Review Used for Cancer Hazard Identification.

Shapiro AJ, Antoni S, Guyton KZ, Lunn RM, Loomis D, Rusyn I, Jahnke GD, Schwingl PJ, Mehta SS, Addington J, Guha N.

Environ Health Perspect. 2018 Oct;126(10):104501. doi: 10.1289/EHP4224.

6.

Tumour virus epidemiology.

Lunn RM, Jahnke GD, Rabkin CS.

Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732). pii: 20160266. doi: 10.1098/rstb.2016.0266. Review.

7.

Health consequences of electric lighting practices in the modern world: A report on the National Toxicology Program's workshop on shift work at night, artificial light at night, and circadian disruption.

Lunn RM, Blask DE, Coogan AN, Figueiro MG, Gorman MR, Hall JE, Hansen J, Nelson RJ, Panda S, Smolensky MH, Stevens RG, Turek FW, Vermeulen R, Carreón T, Caruso CC, Lawson CC, Thayer KA, Twery MJ, Ewens AD, Garner SC, Schwingl PJ, Boyd WA.

Sci Total Environ. 2017 Dec 31;607-608:1073-1084. doi: 10.1016/j.scitotenv.2017.07.056. Epub 2017 Jul 27. Review.

8.

Study sensitivity: Evaluating the ability to detect effects in systematic reviews of chemical exposures.

Cooper GS, Lunn RM, Ågerstrand M, Glenn BS, Kraft AD, Luke AM, Ratcliffe JM.

Environ Int. 2016 Jul-Aug;92-93:605-10. doi: 10.1016/j.envint.2016.03.017. Epub 2016 May 5.

9.

How credible are the study results? Evaluating and applying internal validity tools to literature-based assessments of environmental health hazards.

Rooney AA, Cooper GS, Jahnke GD, Lam J, Morgan RL, Boyles AL, Ratcliffe JM, Kraft AD, Schünemann HJ, Schwingl P, Walker TD, Thayer KA, Lunn RM.

Environ Int. 2016 Jul-Aug;92-93:617-29. doi: 10.1016/j.envint.2016.01.005. Epub 2016 Feb 6.

10.

Research recommendations for selected IARC-classified agents.

Ward EM, Schulte PA, Straif K, Hopf NB, Caldwell JC, Carreón T, DeMarini DM, Fowler BA, Goldstein BD, Hemminki K, Hines CJ, Pursiainen KH, Kuempel E, Lewtas J, Lunn RM, Lynge E, McElvenny DM, Muhle H, Nakajima T, Robertson LW, Rothman N, Ruder AM, Schubauer-Berigan MK, Siemiatycki J, Silverman D, Smith MT, Sorahan T, Steenland K, Stevens RG, Vineis P, Zahm SH, Zeise L, Cogliano VJ.

Environ Health Perspect. 2010 Oct;118(10):1355-62. doi: 10.1289/ehp.0901828. Epub 2010 Jun 18. Review.

11.

Cadmium-induced cancers in animals and in humans.

Huff J, Lunn RM, Waalkes MP, Tomatis L, Infante PF.

Int J Occup Environ Health. 2007 Apr-Jun;13(2):202-12. Review.

12.

Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer.

Brewster AM, Jorgensen TJ, Ruczinski I, Huang HY, Hoffman S, Thuita L, Newschaffer C, Lunn RM, Bell D, Helzlsouer KJ.

Breast Cancer Res Treat. 2006 Jan;95(1):73-80. Epub 2005 Dec 1.

PMID:
16319991
13.

Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma.

Zhang YJ, Chen Y, Ahsan H, Lunn RM, Chen SY, Lee PH, Chen CJ, Santella RM.

Cancer Lett. 2005 Apr 28;221(2):135-43.

PMID:
15808399
15.

High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.

Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM.

Mol Carcinog. 2002 Oct;35(2):85-92.

PMID:
12325038
16.

DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk.

Stern MC, Umbach DM, Lunn RM, Taylor JA.

Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):939-43.

17.

Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls.

Chen SY, Wang LY, Lunn RM, Tsai WY, Lee PH, Lee CS, Ahsan H, Zhang YJ, Chen CJ, Santella RM.

Int J Cancer. 2002 May 1;99(1):14-21.

18.

No association between the XPD (Lys751G1n) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk.

David-Beabes GL, Lunn RM, London SJ.

Cancer Epidemiol Biomarkers Prev. 2001 Aug;10(8):911-2. No abstract available.

19.

Polymorphisms in the DNA repair gene XRCC1 and breast cancer.

Duell EJ, Millikan RC, Pittman GS, Winkel S, Lunn RM, Tse CK, Eaton A, Mohrenweiser HW, Newman B, Bell DA.

Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):217-22.

20.

DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk.

Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA.

Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):125-31.

21.

XPD polymorphisms: effects on DNA repair proficiency.

Lunn RM, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL, Sanford KK, Bell DA.

Carcinogenesis. 2000 Apr;21(4):551-5.

PMID:
10753184
22.
23.

Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).

Lunn RM, Bell DA, Mohler JL, Taylor JA.

Carcinogenesis. 1999 Sep;20(9):1727-31.

PMID:
10469617
24.

XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency.

Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA.

Cancer Res. 1999 Jun 1;59(11):2557-61.

25.

Growth inhibition induced by Ro 31-8220 and calphostin C in human glioblastoma cell lines is associated with apoptosis and inhibition of CDC2 kinase.

Begemann M, Kashimawo SA, Lunn RM, Delohery T, Choi YJ, Kim S, Heitjan DF, Santella RM, Schiff PB, Bruce JN, Weinstein IB.

Anticancer Res. 1998 Sep-Oct;18(5A):3139-52.

PMID:
9858877
26.

p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.

Lunn RM, Zhang YJ, Wang LY, Chen CJ, Lee PH, Lee CS, Tsai WY, Santella RM.

Cancer Res. 1997 Aug 15;57(16):3471-7.

27.

Isolation of cDNA clones for the interferon-induced 67,000-dalton protein: direct induction of a family of mRNAs by human interferon-alpha and interferon-gamma.

Margolis-Nunno H, Rubin BY, Anderson SL, Lunn RM, Roy SN, Dizik M, Sen GC.

J Interferon Res. 1990 Jun;10(3):309-19.

PMID:
1696608
28.

Fragmentation of cellular DNA is a nonspecific indicator of responsiveness to tumor necrosis factor.

Rubin BY, Anderson SL, Lunn RM, Hellermann GR, Smith LJ.

J Biol Response Mod. 1989 Oct;8(5):553-9.

PMID:
2507749
29.

Induction of proteins in interferon-alpha- and interferon-gamma-treated polymorphonuclear leukocytes.

Rubin BY, Anderson SL, Lunn RM, Smith LJ.

J Leukoc Biol. 1989 May;45(5):396-400.

PMID:
2496191
30.

Correlation between the anticellular and DNA fragmenting activities of tumor necrosis factor.

Rubin BY, Smith LJ, Hellermann GR, Lunn RM, Richardson NK, Anderson SL.

Cancer Res. 1988 Nov 1;48(21):6006-10.

31.

The development of antibody to the interferon-induced indoleamine 2,3-dioxygenase and the study of the regulation of its synthesis.

Rubin BY, Anderson SL, Hellermann GR, Richardson NK, Lunn RM, Valinsky JE.

J Interferon Res. 1988 Oct;8(5):691-702.

PMID:
2466915
32.

Tumor necrosis factor and IFN induce a common set of proteins.

Rubin BY, Anderson SL, Lunn RM, Richardson NK, Hellermann GR, Smith LJ, Old LJ.

J Immunol. 1988 Aug 15;141(4):1180-4.

PMID:
2456344
33.

Production of a monoclonal antibody directed against an interferon-induced 56,000-dalton protein and its use in the study of this protein.

Rubin BY, Anderson SL, Lunn RM, Hellermann GR, Richardson NK, Smith LJ.

J Virol. 1988 Jun;62(6):1875-80.

Supplemental Content

Support Center